Novo Nordisk

Novo Nordisk is dedicated to changing possibilities for people with hemophilia and inhibitors.  We are focused on improving treatment options, providing better access to care and following through our commitment to understanding the needs of people with hemophilia.

Novo Nordisk began research and development in hemophilia more than 20 years ago. As a global leader in hemophilia care, Novo Nordisk continues to redefine treatment and develop safe, effective and more convenient approaches; placing control back in the hands of people
with hemophilia, and helping them to lead full and active lives.

For more information on Novo Nordisk, please visit our Web site. - Novo Nordisk